Sort
8,912 grants matching “sars cov 2”
tRNA-derived RNA Fragments and their Role in Nasal SARS-CoV-2 Infection
$240,000Xiaoyong Bao · University Of Texas Med Br Galveston · R21 · FY2022 · AI
RAPID: Design, Fabrication, and Testing a Prototype of Heatable Face Mask for Preventing Respiratory Diseases Contracted through Airborne
$239,990Vesselin N Shanov · University Of Cincinnati Main Campus · · FY2020 · ENG
Origin and host adaptation of the novel canine coronavirus (CCoV-HuPn-2018) isolated from a human pneumonia patient
$239,852Anastasia Nickolaevna Vlasova · Ohio State University · R21 · FY2024 · AI
Immune evasion by SARS-CoV-2: the role of HLA class I
$239,850Marlene Bouvier · University Of Illinois At Chicago · R21 · FY2023 · AI
Development of MMP14-laden exosomes as a novel anti-SARS-CoV-2 therapy
$239,850Kyuyeon Han · University Of Illinois At Chicago · R21 · FY2024 · AI
Identifying and evaluating prevention strategies for COVID-19 in correctional facilities
$239,627Margaret Lind · Boston University Medical Campus · R00 · FY2025 · AI
The impact of the COVID-19 pandemic on adolescent drinking in a longitudinal cohort spanning 21 U.S. cities
$239,625William Ellerbe Pelham III · University Of California, San Diego · R21 · FY2023 · AA
Evaluation of Artemisia as an Effective Combination Therapy Against SARS-CoV-2 Infection
$239,586Joshua Kellogg · Pennsylvania State University, The · R21 · FY2022 · AI
Assessing the efficacy of BCG vaccination in a pre-clinical model of SARS-CoV-2 infection
$239,521Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Assessing the Risk of SARS-CoV-2 Remdesivir Resistance
$239,500Judd F Hultquist · Northwestern University At Chicago · R21 · FY2021 · AI
Rewiring SARS-CoV Genome Organization and Pathogenesis
$239,406Ralph S Baric · Univ Of North Carolina Chapel Hill · P01 · FY2006 · AI
Creation and Validation of cell-based screening systems for SARS-CoV-2 drug targets
$239,250Thomas Melendy · State University Of New York At Buffalo · R21 · FY2022 · AI
Elucidating the role of SERINC5 in SARS-CoV-2 infection
$239,250Spyridon Stavrou · State University Of New York At Buffalo · R21 · FY2022 · AI
Interactions of SARS-CoV-2 N-protein
$239,250Peter Schuck · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2020 · EB
NMR-based discovery of influenza hemagglutinin probes
$239,250Michael S. Caffrey · University Of Illinois At Chicago · R21 · FY2012 · AI
RAPID: PHYSICS OF CORONAVIRUS SARS-COV-2 SURVIVAL OUTSIDE A HOST AND IMPLICATIONS FOR SEASONAL DEPENDENCE OF COVID-19 OUTBREAKS
$238,975Michael D Vershinin · University Of Utah · · FY2020 · MPS
Transforming Urine Output Tracking in Hospitalized Heart Failure Patients
$238,943Lawrence Anthony David · Duke University · R21 · FY2024 · HL
RAPID: Bioinformatic Search for Epitope-based Molecular Mimicry in the SARS-CoV-2 Virus using Chameleon
$238,798Giri Narasimhan · Florida International University · · FY2020 · CSE
MOMI Clinical Core
$238,522Andrea Goldberg Edlow · Massachusetts Institute Of Technology · U19 · FY2025 · AI
SARS-CoV-2 infection of non-human primates
$238,324Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
ENDOTHELIAL AUTONOMOUS MECHANISMS OF EXACERBATED OUTCOMES IN MICE WITH AUTOIMMUNE DEMYELINATING DISEASE AND SARS-COV-2
$238,258University Of Illinois · · FY2021 · Defense Health Agency
Viral exposure signatures may define individuals vulnerable for COVID-19
$238,096Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Identifying the targets of virus-induced PARPs during SARS-CoV-2 infection
$238,025Anthony R Fehr · University Of Kansas Lawrence · R21 · FY2023 · AI
Tomorrow's Science Today: Preparing for the Next Pandemic
$237,833Tim M. Herman · 3d Molecular Designs · R25 · FY2023 · GM
Infectious Influence: Using fate mapping to determine the impact of viral infection sites on Alzheimer's disease initiation
$237,829E. Ashley Moseman · Duke University · R21 · FY2021 · AG